Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
AK-1910 by Asahi Kasei Pharma for Systemic Lupus Erythematosus: Likelihood of Approval
AK-1910 is under clinical development by Asahi Kasei Pharma and currently in Phase I for Systemic Lupus Erythematosus. According to...